N-(2-(2-hydroxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester | 202811-43-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: N-(2-(2-hydroxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester
• 英文别名: N-(2-(2-hydroxyphenyl)ethyl)-N-methylcarbamic acid tert-butyl ester；tert-butyl N-[2-(2-hydroxyphenyl)ethyl]-N-methylcarbamate
• CAS: 202811-43-6
• 化学式: C₁₄H₂₁NO₃
• 分子量: 251.326
• InChiKey: AXPDNXNENCEPIP-UHFFFAOYSA-N

物化性质

• 沸点：
  364.1±21.0 °C(Predicted)
• 密度：
  1.090±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(2-(2-hydroxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester 在 cesium chloride 、 potassium carbonate 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 46.0h， 生成 3-[2-(2-methylamino-ethyl)phenoxy]propan-1-ol
  参考文献：
  名称：

  New highly potent dipeptidic growth hormone secretagogues with low molecular weight

  摘要：

  Based on NN703, low molecular weight growth hormone secretagouges (GHSs) with a reduced number of hydrogen binding sites were designed by removal of the C-terminal amide group. The compounds were highly potent in combination with high efficacy in a rat pituitary cell assay, being characterized with EC50 values down to 0.8 nM. Selected compounds were tested in in vivo animal models. The oral bioavailability in dogs was 16-44%. Also, the ED50 values of the compounds were determined both in dog and swine. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

  DOI：

  10.1016/s0223-5234(00)00160-4
• 作为产物：
  描述：

  2-(2-benzyloxyphenyl)-N-methylacetamide 在 palladium on activated charcoal sodium hydroxide 、 sodium tetrahydroborate 、 氢气 、 碘 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 48.0h， 生成 N-(2-(2-hydroxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester
  参考文献：
  名称：

  New highly potent dipeptidic growth hormone secretagogues with low molecular weight

  摘要：

  Based on NN703, low molecular weight growth hormone secretagouges (GHSs) with a reduced number of hydrogen binding sites were designed by removal of the C-terminal amide group. The compounds were highly potent in combination with high efficacy in a rat pituitary cell assay, being characterized with EC50 values down to 0.8 nM. Selected compounds were tested in in vivo animal models. The oral bioavailability in dogs was 16-44%. Also, the ED50 values of the compounds were determined both in dog and swine. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

  DOI：

  10.1016/s0223-5234(00)00160-4

文献信息

• Compounds with growth hormone releasing properties
  申请人：NOVO NORDISK A/S

  公开号：EP1184370B1

  公开（公告）日：2005-09-14
• COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES
  申请人：NOVO NORDISK A/S

  公开号：EP0923539A1

  公开（公告）日：1999-06-23
• US5922770A
  申请人：——

  公开号：US5922770A

  公开（公告）日：1999-07-13
• US6127354A
  申请人：——

  公开号：US6127354A

  公开（公告）日：2000-10-03
• US6274584B1
  申请人：——

  公开号：US6274584B1

  公开（公告）日：2001-08-14